Yamamoto M - Search Results

1

[A case of advanced gastric cancer responding to combination chemotherapy with low-dose 5-FU plus CDDP].

Ishio T, Kohnoe S, Endo K, Yamamoto M, Ikeda Y, Toh Y, Baba H, Okamura T, Kawamoto K. Ishio T, et al. Among authors: yamamoto m. Gan To Kagaku Ryoho. 2002 Sep;29(9):1627-30. Gan To Kagaku Ryoho. 2002. PMID: 12355950 Japanese.

2

Protracted hepatic arterial infusion with low-dose cisplatin plus 5-fluorouracil for unresectable liver metastases from colorectal cancer.

Kohnoe S, Endo K, Yamamoto M, Ikeda Y, Toh Y, Baba H, Tajima T, Okamura T. Kohnoe S, et al. Among authors: yamamoto m. Surgery. 2002 Jan;131(1 Suppl):S128-34. doi: 10.1067/msy.2002.119364. Surgery. 2002. PMID: 11821799 Clinical Trial.

3

Histone H4 acetylation and histone deacetylase 1 expression in esophageal squamous cell carcinoma.

Toh Y, Yamamoto M, Endo K, Ikeda Y, Baba H, Kohnoe S, Yonemasu H, Hachitanda Y, Okamura T, Sugimachi K. Toh Y, et al. Among authors: yamamoto m. Oncol Rep. 2003 Mar-Apr;10(2):333-8. Oncol Rep. 2003. PMID: 12579268

4

Endoscopic mucosal resection for early cardia cancer by minimum laparotomy.

Endo K, Kawamoto K, Baba H, Yamamoto M, Ikeda Y, Toh Y, Kohnoe S, Okamura T. Endo K, et al. Among authors: yamamoto m. Am J Surg. 2003 Mar;185(3):285-7. doi: 10.1016/s0002-9610(02)01366-1. Am J Surg. 2003. PMID: 12620572

5

Clinical efficacy of S-1 combined with cisplatin for advanced gastric cancer.

Baba H, Yamamoto M, Endo K, Ikeda Y, Toh Y, Kohnoe S, Okamura T. Baba H, et al. Among authors: yamamoto m. Gastric Cancer. 2003;6 Suppl 1:45-9. doi: 10.1007/s10120-003-0222-y. Gastric Cancer. 2003. PMID: 12775020 Clinical Trial.

6

End-to-end anastomosis using a surgical instrument after a segmental resection of the distal duodenum.

Toh Y, Yamamoto M, Endo K, Ikeda Y, Baba H, Kohnoe S, Okamura T. Toh Y, et al. Among authors: yamamoto m. J Surg Oncol. 2004 Feb;85(2):88-90. doi: 10.1002/jso.20002. J Surg Oncol. 2004. PMID: 14755510 No abstract available.

7

Distributions in CEA doubling time differ in patients with recurrent colorectal carcinomas.

Yamamoto M, Maehara Y, Sakaguchi Y, Mine H, Yamanaka T, Korenaga D, Okamura T. Yamamoto M, et al. Hepatogastroenterology. 2004 Jan-Feb;51(55):147-51. Hepatogastroenterology. 2004. PMID: 15011851

8

Postoperative morbidity/mortality and survival rates after total gastrectomy, with splenectomy/pancreaticosplenectomy for patients with advanced gastric cancer.

Yamamoto M, Baba H, Kakeji Y, Endo K, Ikeda Y, Toh Y, Kohnoe S, Okamura T, Maehara Y. Yamamoto M, et al. Hepatogastroenterology. 2004 Jan-Feb;51(55):298-302. Hepatogastroenterology. 2004. PMID: 15011889

9

Prognostic significance of tumor markers in peritoneal lavage in advanced gastric cancer.

Yamamoto M, Baba H, Kakeji Y, Endo K, Ikeda Y, Toh Y, Kohnoe S, Okamura T, Maehara Y. Yamamoto M, et al. Oncology. 2004;67(1):19-26. doi: 10.1159/000080281. Oncology. 2004. PMID: 15459491

10

Akt phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancer.

Oki E, Baba H, Tokunaga E, Nakamura T, Ueda N, Futatsugi M, Mashino K, Yamamoto M, Ikebe M, Kakeji Y, Maehara Y. Oki E, et al. Among authors: yamamoto m. Int J Cancer. 2005 Nov 10;117(3):376-80. doi: 10.1002/ijc.21170. Int J Cancer. 2005. PMID: 15900596

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,366 results

Search Page

Filters